Drug Patent Expirations for the Week of December 22, 2024

By / December 24, 2024

VICTRELIS (boceprevir)

Merck sharp dohmePatent: RE43298Expiration: Dec 22, 2024

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

» Start Your Free Trial Today «

Post navigation

Get Email Updates

Email

Make Better Decisions

See Plans and Pricing

Search for:

Recent Posts

Leveraging a Drug Patent Portfolio for Success
Effective Drug Patent Prosecution Strategies: Securing Your Pharmaceutical Innovations
The Importance of CDMO Flexibility: Adapting to the Ever-Changing Pharmaceutical Landscape
Google Patents: Why It’s a Risky Tool for Finding Drug Patents
How to Evaluate CDMO Performance: Key Considerations and Best Practices

DrugPatentWatch - Make Better Decisions

Scroll to Top

Subscribe to Free Updates3,000+ other biopharma execs get our Drug Patent Expiration Alerts. You should too!

Get fresh news and insights, drug patent expirations & more…

EmailEnter your email address

Thanks, I’m not interested

Last Updated on December 24, 2024 by

Make Better Decisions with DrugPatentWatch

Related Posts